Vivos Therapeutics Total Assets 2011-2026 | VVOS

Total Assets — these are all the resources owned by the business that have economic value. They are used to operate the business, generate profit, and ensure the company’s stability.

Main categories of assets
Current assets (used within one year):

Cash and cash equivalents
Accounts receivable (amounts owed by customers)
Inventory of goods, raw materials, and supplies
Short-term investments

Non-current assets (used for more than one year):

Fixed assets (buildings, machinery, equipment)
Intangible assets (brands, patents, software)
Long-term investments
Goodwill (reputational value from mergers)

Assets represent an objective measure of a business's value, reflecting everything behind it: physical infrastructure, technology, customer base, and financial resources. A high share of liquid assets such as cash indicates a company’s financial flexibility and its ability to maintain stability in changing market conditions.

Asset analysis helps assess how effectively a company utilizes its resources to generate revenue and profit, reflecting its operational efficiency and ability to convert invested capital into financial results.

Annual Total Assets Vivos Therapeutics

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
25.2 M	15.3 M	10.7 M	13.7 M	33.7 M	25.3 M	7.55 M	8.2 M	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
33.7 M	7.55 M	17.5 M

Quarterly Total Assets Vivos Therapeutics

2025-Q3	2025-Q2	2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
25.6 M	26 M	11.3 M	15.3 M	15.3 M	15.8 M	11.8 M	10.7 M	10.3 M	13.7 M	-	13.7 M	18.4 M	24.4 M	29.6 M	33.7 M	41 M	33.7 M	22 M	25.3 M	25.3 M	25.3 M	25.3 M	7.55 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
41 M	7.55 M	20.9 M

Total Assets of other stocks in the Medical devices industry

Issuer	Total Assets	Price	% 24h	Market Cap	Country
EDAP TMS S.A. EDAP	86.1 M	$ 4.13	-0.72 %	$ 155 M	France
Apyx Medical Corporation APYX	66.8 M	$ 3.67	3.09 %	$ 151 M	USA
GenMark Diagnostics, Inc. GNMK	224 M	-	-	$ 1.77 B	USA
Allied Healthcare Products AHPI	19.7 M	-	3.58 %	$ 2.21 M	USA
Obalon Therapeutics, Inc. OBLN	10.6 M	-	-5.86 %	$ 30.6 M	USA
Apollo Endosurgery APEN	110 M	-	-	$ 475 M	USA
Alphatec Holdings ATEC	791 M	$ 7.52	-2.97 %	$ 1.13 B	USA
Aziyo Biologics AZYO	62.4 M	-	1.37 %	$ 20.5 M	USA
Avinger AVGR	13.8 M	-	-20.74 %	$ 369 K	USA
Axonics Modulation Technologies AXNX	659 M	-	-	$ 3.31 B	USA
Helius Medical Technologies HSDT	7.69 M	$ 2.22	3.26 %	$ 1.35 M	USA
BioSig Technologies BSGM	188 M	-	37.08 %	$ 85.7 M	USA
BIOLASE BIOL	35.1 M	-	-13.19 %	$ 166 K	USA
OrthoPediatrics Corp. KIDS	509 M	$ 17.81	1.37 %	$ 418 M	USA
Conformis CFMS	94 M	-	-	$ 16.4 M	USA
LENSAR LNSR	71.4 M	$ 5.64	7.84 %	$ 67.4 M	USA
ClearPoint Neuro CLPT	97.7 M	$ 12.82	9.76 %	$ 363 M	USA
Cardiovascular Systems CSII	323 M	-	0.15 %	$ 844 M	USA
CryoLife, Inc. CRY	789 M	-	-4.14 %	$ 702 M	USA
Cytosorbents Corporation CTSO	44.2 M	$ 0.61	-0.08 %	$ 38 M	USA
LivaNova PLC LIVN	2.61 B	$ 71.86	1.32 %	$ 3.92 B	Britain
Delcath Systems DCTH	124 M	$ 11.48	2.14 %	$ 411 M	USA
Soliton, Inc. SOLY	33.8 M	-	-1.42 %	$ 435 M	USA
Hancock Jaffe Laboratories, Inc. HJLI	10.5 K	-	-1.98 %	$ 98.3 M	USA
Itamar Medical Ltd. ITMR	64.1 M	-	0.03 %	$ 1.58 B	Israel
Orthofix Medical OFIX	851 M	$ 11.65	-3.48 %	$ 461 M	Curacao
Misonix, Inc. MSON	204 M	-	-	$ 462 M	USA
Neovasc NVCN	66.2 M	-	-	$ 111 M	Canada
IRIDEX Corporation IRIX	29.2 M	$ 1.03	-	$ 17.4 M	USA
Dynatronics Corporation DYNT	15.4 M	-	14.99 %	$ 929 K	USA
Eargo EAR	132 M	-	-	$ 10.2 M	USA
Myomo MYO	38.6 M	$ 0.83	-5.05 %	$ 34.7 M	USA
Electromed ELMD	53.8 M	$ 26.93	0.26 %	$ 228 M	USA
Butterfly Network BFLY	256 M	$ 4.16	-2.0 %	$ 881 M	USA
Intersect ENT, Inc. XENT	227 M	-	-	$ 955 M	USA
Second Sight Medical Products EYES	39.4 M	-	-0.97 %	$ 54.4 M	USA
Profound Medical Corp. PROF	77.5 M	$ 6.85	-4.33 %	$ 207 M	Canada
Insulet Corporation PODD	3.19 B	$ 154.16	-3.89 %	$ 10.8 B	USA
GBS GBS	8.25 M	-	-0.57 %	$ 7.12 M	USA
Sintx Technologies SINT	9.51 M	$ 2.35	-2.08 %	$ 6.52 M	USA
Globus Medical GMED	5.3 B	$ 77.95	-8.37 %	$ 10.5 B	USA
CONMED Corporation CNMD	2.33 B	$ 36.76	-3.52 %	$ 1.14 B	USA
Stryker Corporation SYK	47.8 B	$ 285.47	-2.98 %	$ 109 B	USA
Inspire Medical Systems INSP	907 M	$ 44.26	-2.87 %	$ 1.3 B	USA
Integer Holdings Corporation ITGR	3.41 B	$ 88.12	0.23 %	$ 3.06 B	USA
Invacare Corporation IVC	771 M	-	-	$ 24.7 M	USA
Edwards Lifesciences Corporation EW	13.7 B	$ 79.96	-3.44 %	$ 46.8 B	USA
Tandem Diabetes Care TNDM	881 M	$ 15.48	-16.19 %	$ 1.05 B	USA